Sequential Regimen of Bendamustine-Debulking Followed by ABT-199 and GA101-Induction and -Maintenance in CLL (CLL2-BAG)
Clinical trial NCT02401503 · COMPLETED
Trial details
- NCT number
- NCT02401503
- Sponsor
- German CLL Study Group
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-05-06
- Primary completion
- 2024-12-10
- Enrollment
- 66
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.